Accelerating time to insight in Cell & Gene Therapy

Discover the future of cell and gene therapy development with Gyrolab®. Our 20-year proven automated ELISA technology streamlines pharmaceutical research, increasing productivity and data reliability.
Gyrolab® offers an open platform for various applications, optimizing performance, productivity, and throughput. With two instrument configurations, seamless assay transfer and scalability are effortless.
Our technology accelerates immunoassays critical to cell and gene therapies, such as viral titer determination, impurity analysis, immunogenicity assessment, and transgene quantification.
Join us in shaping the future of pharmaceutical research with Gyrolab®.